• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chinese study: a case of H1N1-H3N2 (seasonal) hybrid virus

tetano

Editor, Senior Moderator
Large One study found that a patient suffering from H3N2 and H1N1 new hybrid influenza, the H1N1 virus to increase recombinant attention. Chinese University in 2007 to 2008, on average, 70 years 754 elderly hospitalized because of influenza research, of which 72% of patients with influenza A, influenza B with 28%, 60% for the chronically ill. Study found that 77% of patients with serious influenza-related complications, the total mortality rate was 5.2%. In some patients with chronic diseases of high risk patients, if not received antiviral therapy, the mortality rate as high as 12%. The study also found that appropriate antiviral therapy can reduce mortality by one third. If the patient within 48 hours of onset of the disease are receiving treatment, recovery from the best. The disease within 48-96 hours after the treatment, still help control severe influenza illness. Study also found a patient suffering from H3N2 and H1N1 new hybrid influenza H1N1 virus genes to increase the concerns of restructuring. Large urged doctors to isolate influenza patients to prevent cross-infection of patients and virus variants. CUHK also called high risk groups such as the flu symptoms should immediately accept the HIV test and receiving appropriate antiviral treatment to expedite recovery and reduce disease mortality. (News)

http://news.sina.com.hk/cgi-bin/nw/show.cgi/32/1/1/1516050/1.html
 
Back
Top